Beyond biomarkers in drug discovery and development

被引:0
|
作者
Steensberg, Adam [1 ]
Simons, Tad D. [2 ]
机构
[1] Zealand Pharma, DK-2600 Glostrup, Denmark
[2] Pyxera Inc, Mountain View, CA 94041 USA
关键词
D O I
10.1016/j.drudis.2014.12.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:289 / 291
页数:3
相关论文
共 50 条
  • [1] Clinical biomarkers in drug discovery and development
    Frank, R
    Hargreaves, R
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (07) : 566 - 580
  • [2] Challenges of biomarkers in drug discovery and development
    Goodsaid, Federico
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2012, 7 (06) : 457 - 461
  • [3] Clinical biomarkers in drug discovery and development
    Richard Frank
    Richard Hargreaves
    [J]. Nature Reviews Drug Discovery, 2003, 2 : 566 - 580
  • [4] Challenges with biomarkers in cancer drug discovery and development
    Dumbrava, Ecaterina Ileana
    Meric-Bernstam, Funda
    Yap, Timothy A.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (08) : 685 - 690
  • [5] Discovery of Biomarkers of Response in Early Drug Development
    O'Byrne, Sharon
    Kaser, Arthur
    Parik, Asit
    Chowers, Yehuda
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S560 - S566
  • [6] Neuroimaging Biomarkers for Drug Discovery and Development in Schizophrenia
    Preller, Katrin H.
    Scholpp, Joachim
    Wunder, Andreas
    Rosenbrock, Holger
    [J]. BIOLOGICAL PSYCHIATRY, 2024, 96 (08) : 666 - 673
  • [7] Drug discovery and development: Biomarkers of neurotoxicity and neurodegeneration
    Walker, Abigail L.
    Imam, Syed Z.
    Roberts, Ruth A.
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 243 (13) : 1037 - 1045
  • [8] Beyond Deterministic Models in Drug Discovery and Development
    Irurzun-Arana, Itziar
    Rackauckas, Christopher
    McDonald, Thomas O.
    Troconiz, Inaki F.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (11) : 882 - 895
  • [9] Ayurveda for science: Drug discovery, development, and beyond
    Patwardhan, Bhushan
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [10] Safety biomarkers: Opportunities and challenges in drug discovery and development
    Schuppe-Koistinen, Ina
    [J]. TOXICOLOGY LETTERS, 2012, 211 : S9 - S9